Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
26.28
-0.41 (-1.54%)
At close: Aug 18, 2025, 3:59 PM
26.25
-0.11%
After-hours: Aug 18, 2025, 07:53 PM EDT
Summit Therapeutics Revenue
Summit Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Summit Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
159
Market Cap
19.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | -100.00% |
| Dec 31, 2022 | 704.29K | -61.07% |
| Dec 31, 2021 | 1.81M | +110.35% |
| Dec 31, 2020 | 860K | +40.55% |
| Dec 31, 2019 | 611.87K | -98.92% |
| Jan 31, 2019 | 56.41M | +222.45% |
| Jan 31, 2018 | 17.5M | +507.47% |
| Jan 31, 2017 | 2.88M | +124.82% |
| Jan 31, 2016 | 1.28M | -43.52% |
| Jan 31, 2015 | 2.27M | n/a |
| Jan 31, 2014 | 2.27M | -20.84% |
| Jan 31, 2013 | 2.87M | +3.35% |
| Jan 31, 2012 | 2.77M | +129.66% |
| Jan 31, 2011 | 1.21M | +299.74% |
| Jan 31, 2010 | 301.94K | +13.24% |
| Jan 31, 2009 | 266.64K | -95.57% |
| Jan 31, 2008 | 6.03M | +197.09% |
| Jan 31, 2007 | 2.03M | +113.95% |
| Jan 31, 2006 | 947.89K | +345.52% |
| Jan 31, 2005 | 212.76K | +11561.43% |
| Jan 31, 2004 | 1.82K | n/a |